CompletedNot Applicable

Retrospective Evaluation of Ultrasound-assisted Tumor Surgery in Breast-conserving Therapy

Germany273 participantsStarted 2020-01-01

Plain-language summary

The aim of this study is to evaluate whether standardizing intraoperative ultrasound (IOUS) with the "Tübingen Ultrasound Ruler" reduces R1 resection rates in breast-conserving surgery.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age at least 18 years and no more than 80 years (inclusive) * Preoperatively histologically confirmed breast cancer, detectable by ultrasound * Unifocal to multifocal findings * Palpable and/or non-palpable findings * Indication for breast-conserving therapy (BCT) Exclusion Criteria: * Sonographically ambiguous findings * Multicentricity * Exclusion criteria for BCT * Status after neoadjuvant chemotherapy

What they're measuring

R1 resection rates

Timeframe: 3 years

Trial details

NCT IDNCT07519668

SponsorUniversity Hospital Tuebingen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More Breast Cancer trials